Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML

Abroad (travel likely)RecruitingPHASE2

Conditions

Acute Myeloid Leukemia · FLT3 Internal Tandem Duplication Positive · Intermediate Risk Acute Myeloid Leukemia · Fit Patients

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

    Contact: Study coordinator (Jie Sun, MD,PH.D) · jsun1492@zju.edu.cn · +8613867439726